PER 1.88% 7.9¢ percheron therapeutics limited

For General Information, page-794

  1. 3,549 Posts.
    lightbulb Created with Sketch. 771
    Just a quick question for the clever bunch here....we always talk about Sarepta and they may be interested in our program or whatever...But I would like to know which Pharmas are located in Europe that have interest in the DMD space...I know about Roche which is possibly Switzerland / Europe...

    Anyone knows any other companies involved in the DMD space in Europe??

    Just thinking as we plan to start the EMA trials and obviously we are targeting Europe as our first market to sell the drug...so any competition might be aware of how we are going with our trials / process.

    Practically thinking Sarepta would be least interested as US market is a long way off ( untill we get positive EMA data and approach the FDA) with regards to actual getting the approval to sell in the US...

    Thanks in advance....get all these idea when I have my beer ..lol

    Cheers everyone ...and Good luck ..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(1.88%)
Mkt cap ! $70.77M
Open High Low Value Volume
8.0¢ 8.2¢ 7.8¢ $66.20K 831.8K

Buyers (Bids)

No. Vol. Price($)
3 216590 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 24573 1
View Market Depth
Last trade - 15.45pm 17/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.